2 reports

  • CAR-T
  • 9.2.2.3. CAR-T THERAPY AND RESEARCH LANDSCAPE

INTRODUCTION Amidst the current initiatives to develop more targeted anti-cancer therapies, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a potent and viable therapeutic intervention to eradicate tumor cells, with minimal side effects. It is based on the principle of harnessing the innate potential of...

  • Automotive
  • Clinical Trial
  • Motor Vehicle
  • Therapy
  • Celgene Corporation
  • 8. MARKET FORECAST

ONE STEP FORWARD IN THIS DIRECTION WAS THE FIRST HUMAN TRIAL OF AN ANTI-BCMA CAR-T THERAPY.

  • Motor Vehicle
  • Targeted Therapy
  • Therapy
  • Affimed Therapeutics AG
  • Celgene Corporation